| Year |
Citation |
Score |
| 2023 |
Hunger J, Schregel K, Boztepe B, Agardy DA, Turco V, Karimian-Jazi K, Weidenfeld I, Streibel Y, Fischer M, Sturm V, Santarella-Mellwig R, Kilian M, Jähne K, Sahm K, Wick W, ... ... Platten M, et al. nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental glioma. Theranostics. 13: 5170-5182. PMID 37908732 DOI: 10.7150/thno.87248 |
0.671 |
|
| 2023 |
Grassl N, Poschke I, Lindner K, Bunse L, Mildenberger I, Boschert T, Jähne K, Green EW, Hülsmeyer I, Jünger S, Kessler T, Suwala AK, Eisele P, Breckwoldt MO, Vajkoczy P, ... ... Platten M, et al. A H3K27M-targeted vaccine in adults with diffuse midline glioma. Nature Medicine. 29: 2586-2592. PMID 37735561 DOI: 10.1038/s41591-023-02555-6 |
0.675 |
|
| 2023 |
Schregel K, Heinz L, Hunger J, Pan C, Bode J, Fischer M, Sturm V, Venkataramani V, Karimian-Jazi K, Agardy DA, Streibel Y, Zerelles R, Wick W, Heiland S, Bunse T, ... ... Platten M, et al. A cellular ground truth to develop MRI signatures in glioma models by correlative light sheet microscopy and atlas-based co-registration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 37429718 DOI: 10.1523/JNEUROSCI.1470-22.2023 |
0.696 |
|
| 2023 |
Turco V, Pfleiderer K, Hunger J, Horvat NK, Karimian-Jazi K, Schregel K, Fischer M, Brugnara G, Jähne K, Sturm V, Streibel Y, Nguyen D, Altamura S, Agardy DA, Soni SS, ... ... Platten M, et al. T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles. Nature Communications. 14: 771. PMID 36774352 DOI: 10.1038/s41467-023-36321-6 |
0.723 |
|
| 2022 |
Miller JJ, Gonzalez Castro LN, McBrayer S, Weller M, Cloughesy T, Portnow J, Andronesi O, Barnholtz-Sloan JS, Baumert BG, Berger MS, Bi WL, Bindra R, Cahill DP, Chang SM, Costello JF, ... ... Platten M, et al. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro-Oncology. PMID 36239925 DOI: 10.1093/neuonc/noac207 |
0.447 |
|
| 2022 |
Reinhardt A, Pfister K, Schrimpf D, Stichel D, Sahm F, Reuss DE, Capper D, Wefers AK, Ebrahimi A, Sill M, Felsberg J, Reifenberger G, Becker A, Prinz M, Staszewski O, ... ... Platten M, et al. Anaplastic ganglioglioma - a diagnosis comprising several distinct tumour types. Neuropathology and Applied Neurobiology. e12847. PMID 35977725 DOI: 10.1111/nan.12847 |
0.397 |
|
| 2021 |
Kilian M, Friedrich M, Sanghvi K, Green E, Pusch S, Kawauchi D, Löwer M, Sonner JK, Krämer C, Zaman J, Jung S, Breckwoldt MO, Willimksy G, Eichmüller SB, von Deimling A, ... ... Platten M, et al. T cell receptor therapy targeting mutant capicua transcriptional repressor in experimental gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34782365 DOI: 10.1158/1078-0432.CCR-21-1881 |
0.681 |
|
| 2021 |
Blobner J, Kilian M, Tan CL, Aslan K, Sanghvi K, Meyer J, Fischer M, Jähne K, Breckwoldt MO, Sahm F, von Deimling A, Bendszus M, Wick W, Platten M, Green E, et al. Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes. Neuro-Oncology Advances. 3: vdab147. PMID 34738084 DOI: 10.1093/noajnl/vdab147 |
0.681 |
|
| 2021 |
Platten M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, Sahm F, Sanghvi K, Tan CL, Poschke I, Green E, Justesen S, Behrens GA, Breckwoldt MO, Freitag A, et al. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature. PMID 33762734 DOI: 10.1038/s41586-021-03363-z |
0.675 |
|
| 2021 |
Koelsche C, Schrimpf D, Stichel D, Sill M, Sahm F, Reuss DE, Blattner M, Worst B, Heilig CE, Beck K, Horak P, Kreutzfeldt S, Paff E, Stark S, Johann P, ... ... Platten M, et al. Sarcoma classification by DNA methylation profiling. Nature Communications. 12: 498. PMID 33479225 DOI: 10.1038/s41467-020-20603-4 |
0.366 |
|
| 2020 |
Hahn A, Bode J, Alexander A, Karimian-Jazi K, Schregel K, Schwarz D, Sommerkamp AC, Krüwel T, Abdollahi A, Wick W, Platten M, Bendszus M, Tews B, Kurz FT, Breckwoldt MO. Large-scale characterization of the microvascular geometry in development and disease by tissue clearing and quantitative ultramicroscopy. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20961854. PMID 33043767 DOI: 10.1177/0271678X20961854 |
0.658 |
|
| 2020 |
Kickingereder P, Brugnara G, Hansen MB, Nowosielski M, Pflüger I, Schell M, Isensee F, Foltyn M, Neuberger U, Kessler T, Sahm F, Wick A, Heiland S, Weller M, Platten M, et al. Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial. Radiology. 200978. PMID 32720870 DOI: 10.1148/Radiol.2020200978 |
0.374 |
|
| 2020 |
Grassl N, Bunse L, Beutel T, Klockziem M, Gass A, Platten M, Eisele P. Nivolumab for Treatment of Progressive Multifocal Leukoencephalopathy in Sézary Syndrome. European Journal of Neurology. PMID 32644207 DOI: 10.1111/Ene.14433 |
0.334 |
|
| 2020 |
Kudo T, Prentzell MT, Mohapatra SR, Sahm F, Zhao Z, Grummt I, Wick W, Opitz CA, Platten M, Green EW. Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβ. Frontiers in Immunology. 11: 657. PMID 32477324 DOI: 10.3389/Fimmu.2020.00657 |
0.345 |
|
| 2020 |
Schell M, Pflüger I, Brugnara G, Isensee F, Neuberger U, Foltyn M, Kessler T, Sahm F, Wick A, Nowosielski M, Heiland S, Weller M, Platten M, Maier-Hein KH, von Deimling A, et al. Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial. Neuro-Oncology. PMID 32393964 DOI: 10.1093/Neuonc/Noaa120 |
0.304 |
|
| 2020 |
Wen PY, Weller M, Lee EQ, Alexander BA, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF, DeGroot JF, Galanis E, Gilbert MR, Hegi ME, ... ... Platten M, et al. Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions. Neuro-Oncology. PMID 32328653 DOI: 10.1093/Neuonc/Noaa106 |
0.337 |
|
| 2020 |
Aslan K, Turco V, Blobner J, Sonner JK, Liuzzi AR, Núñez NG, De Feo D, Kickingereder P, Fischer M, Green E, Sadik A, Friedrich M, Sanghvi K, Kilian M, Cichon F, ... ... Platten M, et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nature Communications. 11: 931. PMID 32071302 DOI: 10.1038/S41467-020-14642-0 |
0.705 |
|
| 2020 |
Karimian-Jazi K, Münch P, Alexander A, Fischer M, Pfleiderer K, Piechutta M, Karreman MA, Solecki GM, Berghoff AS, Friedrich M, Deumelandt K, Kurz FT, Wick W, Heiland S, Bendszus M, ... ... Platten M, et al. Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM). Theranostics. 10: 1873-1883. PMID 32042342 DOI: 10.7150/thno.38659 |
0.69 |
|
| 2019 |
Opitz CA, Somarribas Patterson LF, Mohapatra SR, Dewi DL, Sadik A, Platten M, Trump S. The therapeutic potential of targeting tryptophan catabolism in cancer. British Journal of Cancer. PMID 31819194 DOI: 10.1038/S41416-019-0664-6 |
0.305 |
|
| 2019 |
Reinhardt A, Stichel D, Schrimpf D, Koelsche C, Wefers AK, Ebrahimi A, Sievers P, Huang K, Casalini MB, Fernández-Klett F, Suwala A, Weller M, Gramatzki D, Felsberg J, Reifenberger G, ... ... Platten M, et al. Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities. Acta Neuropathologica Communications. 7: 163. PMID 31661039 DOI: 10.1186/S40478-019-0801-8 |
0.655 |
|
| 2019 |
Shraibman B, Barnea E, Kadosh DM, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, ... ... Platten M, et al. Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. Molecular & Cellular Proteomics : McP. 18: 1270. PMID 31154440 DOI: 10.1074/Mcp.W119.001571 |
0.351 |
|
| 2019 |
Nowosielski M, Gorlia T, Bromberg JEC, Sahm F, Harting I, Kickingereder P, Brandes AA, Taphoorn MJB, Taal W, Domont J, Idbaih A, Campone M, Clement PM, Weller M, Fabbro M, ... ... Platten M, et al. Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study. Neurology. PMID 31076534 DOI: 10.1212/Wnl.0000000000007643 |
0.309 |
|
| 2019 |
Schwarz D, Niederle T, Münch P, Hielscher T, Hassel JC, Schlemmer HP, Platten M, Winkler F, Wick W, Heiland S, Delorme S, Bendszus M, Bäumer P, Breckwoldt MO. Susceptibility-weighted imaging in malignant melanoma brain metastasis. Journal of Magnetic Resonance Imaging : Jmri. PMID 30793419 DOI: 10.1002/Jmri.26692 |
0.67 |
|
| 2019 |
Eisele P, Konstandin S, Szabo K, Ebert A, Roßmanith C, Paschke N, Kerschensteiner M, Platten M, Schoenberg SO, Schad LR, Gass A. Temporal evolution of acute multiple sclerosis lesions on serial sodium (Na) MRI. Multiple Sclerosis and Related Disorders. 29: 48-54. PMID 30669020 DOI: 10.1016/J.Msard.2019.01.027 |
0.607 |
|
| 2019 |
Wick W, Wick A, Platten M, Chinot OL, Van Den Bent MJ, Dhermain F, Mansour M, Podola L, Lubenau H. Oral DNA vaccination targeting VEGFR-2 combined with anti-PD-L1 avelumab in patients with progressive glioblastoma, a phase I/II study: NCT03750071. Journal of Clinical Oncology. 37: TPS2076-TPS2076. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps2076 |
0.352 |
|
| 2019 |
Wick W, Kessler T, Platten M, Meisner C, Bamberg M, Herrlinger U, Happold C, Weisang S, Boelting H, Steinbach J, Reifenberger G, Sahm F, von Deimling A, Wick A, Weller M. Impact of predictive impact of MGMT promoter methylation in malignant astrocytomas depends on the methylation subgroup. Journal of Clinical Oncology. 37: 2013-2013. DOI: 10.1200/Jco.2019.37.15_Suppl.2013 |
0.327 |
|
| 2019 |
Friedrich M, Bunse L, Bunse T, Green E, Kessler T, Pusch S, Deumelandt K, Carretero R, Deimling Av, Quintana FJ, Wick W, Platten M. Abstract PR15: The oncometabolite R-2-Hydroxyglutarate suppresses the innate immune microenvironment of IDH1-mutated gliomas via aryl hydrocarbon receptor signaling Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-Pr15 |
0.369 |
|
| 2019 |
Deumelandt K, Blobner J, Sonner JK, Friedrich M, Green E, Breckwoldt MO, Fischer M, Meyer J, Sahm F, Schrimpf D, Deimling Av, Platten M. Abstract B075: Modeling response and resistance to immune checkpoint blockade in syngeneic mouse glioma Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B075 |
0.387 |
|
| 2019 |
Ulges A, Hilf N, Wick W, Platten M, Dietrich P, Frenzel K, Admon A, Burg SSHvd, Deimling Av, Straten Pt, Gouttefangeas C, Kroep JR, Martínez-Ricarte F, Okada H, Ottensmeier CH, et al. Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A020 |
0.348 |
|
| 2019 |
Schmees N, Gutcher I, Roehn U, Irlbacher H, Stoeckigt D, Bader B, Kober C, Roese L, Carretero R, Oezen I, Zorn L, Platten M, Hartung IV, Kreft B, Weinmann H. Abstract 4454: Identification of BAY-218, a potent and selective small-molecule AhR inhibitor, as a new modality to counteract tumor immunosuppression Cancer Research. 79: 4454-4454. DOI: 10.1158/1538-7445.Am2019-4454 |
0.368 |
|
| 2018 |
Breckwoldt MO, Bode J, Sahm F, Krüwel T, Solecki G, Hahn A, Wirthschaft P, Berghoff AS, Haas M, Venkataramani V, von Deimling A, Wick W, Herold-Mende C, Heiland S, Platten M, et al. Correlated MRI and Ultramicroscopy (MR-UM) of Brain Tumors Reveals Vast Heterogeneity of Tumor Infiltration and Neoangiogenesis in Preclinical Models and Human Disease. Frontiers in Neuroscience. 12: 1004. PMID 30686972 DOI: 10.3389/Fnins.2018.01004 |
0.71 |
|
| 2018 |
Hoffmann A, Pfeil J, Mueller AK, Jin J, Deumelandt K, Helluy X, Wang C, Heiland S, Platten M, Chen JW, Bendszus M, Breckwoldt MO. MRI of Iron Oxide Nanoparticles and Myeloperoxidase Activity Links Inflammation to Brain Edema in Experimental Cerebral Malaria. Radiology. 181051. PMID 30615566 DOI: 10.1148/Radiol.2018181051 |
0.669 |
|
| 2018 |
Adam I, Dewi DL, Mooiweer J, Sadik A, Mohapatra SR, Berdel B, Keil M, Sonner JK, Thedieck K, Rose AJ, Platten M, Heiland I, Trump S, Opitz CA. Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation. Oncoimmunology. 7: e1486353. PMID 30524887 DOI: 10.1080/2162402X.2018.1486353 |
0.333 |
|
| 2018 |
Wick W, Dettmer S, Berberich A, Kessler T, Karapanagiotou-Schenkel I, Wick A, Winkler F, Pfaff E, Brors B, Debus J, Unterberg A, Bendszus M, Herold-Mende C, Eisenmenger A, von Deimling A, ... ... Platten M, et al. N2M2 (NOA20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma. Neuro-Oncology. PMID 30277538 DOI: 10.1093/Neuonc/Noy161 |
0.315 |
|
| 2018 |
Berberich A, Kessler T, Thomé CM, Pusch S, Hielscher T, Sahm F, Oezen I, Schmitt LM, Ciprut S, Hucke N, Rübmann P, Fischer M, Lemke D, Breckwoldt MO, von Deimling A, ... ... Platten M, et al. Targeting resistance against the MDM2 inhibitor RG7388 in glioblastoma cells by the MEK inhibitor trametinib. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30274984 DOI: 10.1158/1078-0432.Ccr-18-1580 |
0.66 |
|
| 2018 |
Platten M. T cells engineered to home in on brain cancer. Nature. 561: 319-320. PMID 30224728 DOI: 10.1038/D41586-018-05883-7 |
0.311 |
|
| 2018 |
Friedrich M, Bunse L, Wick W, Platten M. Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas. Current Opinion in Oncology. PMID 30102604 DOI: 10.1097/Cco.0000000000000478 |
0.316 |
|
| 2018 |
Shraibman B, Barnea E, Melamed Kadosh D, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, ... ... Platten M, et al. Identification of tumor antigens among the HLA peptidomes of Glioblastoma tumors and plasma. Molecular & Cellular Proteomics : McP. PMID 30072578 DOI: 10.1074/Mcp.Ra118.000792 |
0.355 |
|
| 2018 |
Berberich A, Hielscher T, Kickingereder P, Winkler F, Drüschler K, Riedemann L, Arzt M, Kessler T, Platten M, von Deimling A, Wick W, Sahm F, Bendszus M, Wick A. Non-measurable speckled contrast-enhancing lesions appearing during course of disease are associated with IDH mutation in high-grade astrocytoma patients. International Journal of Radiation Oncology, Biology, Physics. PMID 30071292 DOI: 10.1016/J.Ijrobp.2018.07.2004 |
0.343 |
|
| 2018 |
Bunse L, Pusch S, Bunse T, Sahm F, Sanghvi K, Friedrich M, Alansary D, Sonner JK, Green E, Deumelandt K, Kilian M, Neftel C, Uhlig S, Kessler T, von Landenberg A, ... ... Platten M, et al. Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nature Medicine. PMID 29988124 DOI: 10.1038/S41591-018-0095-6 |
0.736 |
|
| 2018 |
Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D, Sill M, Schmid S, Hovestadt V, Reuss DE, Koelsche C, Reinhardt A, Wefers AK, Huang K, Sievers P, Ebrahimi A, ... ... Platten M, et al. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathologica. PMID 29967940 DOI: 10.1007/S00401-018-1879-Y |
0.339 |
|
| 2018 |
Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss DE, Sahm F, Koelsche C, Wefers A, Reinhardt A, Huang K, Sievers P, Shimizu H, Nanjo H, Kobayashi Y, Miyake Y, ... ... Platten M, et al. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Acta Neuropathologica. PMID 29687258 DOI: 10.1007/S00401-018-1849-4 |
0.563 |
|
| 2018 |
Yamauchi Y, Safi S, Blattner C, Rathinasamy A, Umansky L, Juenger S, Warth A, Eichhorn M, Muley T, Herth FJF, Dienemann H, Platten M, Beckhove P, Utikal J, Hoffmann H, et al. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-small-cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. PMID 29617574 DOI: 10.1164/Rccm.201708-1707Oc |
0.365 |
|
| 2018 |
Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, Huang K, Wefers AK, Hovestadt V, Sill M, Gramatzki D, Felsberg J, Reifenberger G, Koch A, ... ... Platten M, et al. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathologica. PMID 29564591 DOI: 10.1007/S00401-018-1837-8 |
0.707 |
|
| 2018 |
Platten M, Reardon DA. Concepts for Immunotherapies in Gliomas. Seminars in Neurology. 38: 62-72. PMID 29548053 DOI: 10.1055/S-0037-1620274 |
0.393 |
|
| 2018 |
Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, ... ... Platten M, et al. DNA methylation-based classification of central nervous system tumours. Nature. PMID 29539639 DOI: 10.1038/Nature26000 |
0.653 |
|
| 2018 |
Schwarzbach CJ, Ebert A, Hennerici MG, Neumaier-Probst E, Platten M, Fatar M. Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma. Therapeutic Advances in Neurological Disorders. 11: 1756285617753423. PMID 29449886 DOI: 10.1177/1756285617753423 |
0.314 |
|
| 2018 |
Rabe JH, A Sammour D, Schulz S, Munteanu B, Ott M, Ochs K, Hohenberger P, Marx A, Platten M, Opitz CA, Ory DS, Hopf C. Fourier Transform Infrared Microscopy Enables Guidance of Automated Mass Spectrometry Imaging to Predefined Tissue Morphologies. Scientific Reports. 8: 313. PMID 29321555 DOI: 10.1038/S41598-017-18477-6 |
0.319 |
|
| 2018 |
Wick W, Wick A, Sahm F, Riehl D, von Deimling A, Bendszus M, Kickingereder P, Beckhove P, Schmitz-Winnenthal FH, Jungk C, Wieckowski S, Podola L, Herold-Mende C, Unterberg A, Platten M. VXM01 phase I study in patients with progressive glioblastoma: Final results. Journal of Clinical Oncology. 36: 2017-2017. DOI: 10.1200/Jco.2018.36.15_Suppl.2017 |
0.344 |
|
| 2018 |
Lu K, Bunse L, Sahm F, Sanghvi K, Ratliff M, Hänggi D, von Deimling A, Sahin U, Wick W, Green E, Platten M. P04.52 Spontaneous intratumoral T cell responses against glioblastoma-associated antigens Neuro-Oncology. 20: iii291-iii291. DOI: 10.1093/Neuonc/Noy139.286 |
0.305 |
|
| 2018 |
Zhang X, Sahm K, Sonner J, Jähne K, Breckwoldt M, Piechutta M, Häring P, Winkler F, Wick W, Platten M. P04.34 Low-dose irradiation increases recruitment and effector function of tumor-specific T cells in experimental gliomas Neuro-Oncology. 20: iii286-iii286. DOI: 10.1093/Neuonc/Noy139.268 |
0.363 |
|
| 2017 |
Costa da Silva M, Breckwoldt MO, Vinchi F, Correia MP, Stojanovic A, Thielmann CM, Meister M, Muley T, Warth A, Platten M, Hentze MW, Cerwenka A, Muckenthaler MU. Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages. Frontiers in Immunology. 8: 1479. PMID 29167669 DOI: 10.3389/Fimmu.2017.01479 |
0.672 |
|
| 2017 |
Pfaff E, Kessler T, Balasubramanian GP, Berberich A, Schrimpf D, Wick A, Debus J, Unterberg A, Bendszus M, Herold-Mende C, Capper D, Schenkel I, Eisenmenger A, Dettmer S, Brors B, ... Platten M, et al. Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter-hypermethylation - the NCT Neuro Master Match (N2M2) pilot study. Neuro-Oncology. PMID 29165638 DOI: 10.1093/Neuonc/Nox216 |
0.352 |
|
| 2017 |
Wick A, Kessler T, Elia AEH, Winkler F, Batchelor TT, Platten M, Wick W. Glioblastoma in the elderly: solid conclusions built on shifting sand? Neuro-Oncology. PMID 29016815 DOI: 10.1093/Neuonc/Nox133 |
0.301 |
|
| 2017 |
Kessler T, Sahm F, Sadik A, Stichel D, Hertenstein A, Reifenberger G, Zacher A, Sabel M, Tabatabai G, Steinbach J, Sure U, Krex D, Grosu AL, Bewerunge-Hudler M, Jones D, ... ... Platten M, et al. Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation. Neuro-Oncology. PMID 29016808 DOI: 10.1093/Neuonc/Nox160 |
0.318 |
|
| 2017 |
Ochs K, Ott M, Bunse T, Sahm F, Bunse L, Deumelandt K, Sonner JK, Keil M, von Deimling A, Wick W, Platten M. K27M-mutant histone-3 as a novel target for glioma immunotherapy. Oncoimmunology. 6: e1328340. PMID 28811969 DOI: 10.1080/2162402X.2017.1328340 |
0.348 |
|
| 2017 |
Eisele P, Szabo K, Alonso A, Ong M, Platten M, Schoenberg SO, Gass A. Lack of T1 hyperintensity in the dentate nucleus after 15 administrations of a macrocyclic contrast agent in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28710325 DOI: 10.1136/Jnnp-2017-316102 |
0.313 |
|
| 2017 |
Jung E, Osswald M, Blaes J, Wiestler B, Sahm F, Schmenger T, Solecki G, Deumelandt K, Kurz FT, Xie R, Weil S, Heil O, Thomé C, Gömmel M, Syed M, ... ... Platten M, et al. Tweety-homologue 1 drives brain colonization of gliomas. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28607172 DOI: 10.1523/Jneurosci.3532-16.2017 |
0.412 |
|
| 2017 |
Weller M, Roth P, Preusser M, Wick W, Reardon DA, Platten M, Sampson JH. Vaccine-based immunotherapeutic approaches to gliomas and beyond. Nature Reviews. Neurology. PMID 28497804 DOI: 10.1038/Nrneurol.2017.64 |
0.33 |
|
| 2017 |
Lanz TV, Williams SK, Stojic A, Iwantscheff S, Sonner JK, Grabitz C, Becker S, Böhler LI, Mohapatra SR, Sahm F, Küblbeck G, Nakamura T, Funakoshi H, Opitz CA, Wick W, ... ... Platten M, et al. Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis. Scientific Reports. 7: 41271. PMID 28117398 DOI: 10.1038/Srep41271 |
0.32 |
|
| 2017 |
Wick W, Wick A, Nowosielski M, Sahm F, Riehl D, Arzt M, von Deimling A, Bendszus M, Kickingereder P, Bonekamp D, Beckhove P, Schmitz-Winnenthal FH, Jungk C, Wieckowski S, Herold-Mende C, ... ... Platten M, et al. VXM01 phase I study in patients with resectable progression of a glioblastoma. Journal of Clinical Oncology. 35: 2061-2061. DOI: 10.1200/JCO.2017.35.15_SUPPL.2061 |
0.3 |
|
| 2017 |
Nowosielski M, Gorlia T, Bromberg J, Sahm F, Harting I, Kickingereder P, Brandes A, Taphoorn MJB, Taal W, Domont J, Idbaih A, Campone M, Clement P, Weller M, Fabbro M, ... ... Platten M, et al. NIMG-75. NECROSIS DURING TREATMENT IS ASSOCIATED WITH WORSE SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS – POST HOC IMAGE ANALYSIS OF EORTC 26101 Neuro-Oncology. 19: vi159-vi159. DOI: 10.1093/Neuonc/Nox168.647 |
0.303 |
|
| 2017 |
Klein M, Reijneveld JC, Idbaih A, Brandes A, Taal W, Clement PM, Domont J, Campone M, Taphoorn MJB, Stupp R, Fabbro M, Rhun EL, Dubois F, Weller M, Golfinopoulos V, ... Platten M, et al. NCOG-19. NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION Neuro-Oncology. 19: vi142-vi142. DOI: 10.1093/Neuonc/Nox168.580 |
0.361 |
|
| 2017 |
Sanghvi K, Green E, Bunse L, Balasubramanian GP, Hertenstein A, Bunse T, Jones D, Sahm F, Wick W, Platten M. P06.08 BRAINTuNE: Brain Tumor Neoepitope Evaluation for personalized glioma immunotherapy Neuro-Oncology. 19: iii50-iii51. DOI: 10.1093/Neuonc/Nox036.182 |
0.411 |
|
| 2016 |
Breckwoldt MO, Gradl J, Hähnel S, Hielscher T, Wildemann B, Diem R, Platten M, Wick W, Heiland S, Bendszus M. Increasing the sensitivity of MRI for the detection of multiple sclerosis lesions by long axial coverage of the spinal cord: a prospective study in 119 patients. Journal of Neurology. PMID 27909801 DOI: 10.1007/s00415-016-8353-3 |
0.625 |
|
| 2016 |
Schliesser MG, Claus R, Hielscher T, Grimm C, Weichenhan D, Blaes J, Wiestler B, Hau P, Schramm J, Sahm F, Weiß EK, Weiler M, Baer C, Schmidt-Graf F, Schackert G, ... ... Platten M, et al. Prognostic relevance of miRNA-155 methylation in anaplastic glioma. Oncotarget. PMID 27880937 DOI: 10.18632/Oncotarget.13452 |
0.405 |
|
| 2016 |
Kirschbaum K, Sonner JK, Zeller MW, Deumelandt K, Bode J, Sharma R, Krüwel T, Fischer M, Hoffmann A, Costa da Silva M, Muckenthaler MU, Wick W, Tews B, Chen JW, Heiland S, ... ... Platten M, et al. In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 27799546 DOI: 10.1073/pnas.1609397113 |
0.647 |
|
| 2016 |
Wick W, Roth P, Hartmann C, Hau P, Nakamura M, Stockhammer F, Sabel MC, Wick A, Koeppen S, Ketter R, Vajkoczy P, Eyupoglu I, Kalff R, Happold C, Galldiks N, ... ... Platten M, et al. Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. Neuro-Oncology. PMID 27370396 DOI: 10.1093/Neuonc/Now133 |
0.381 |
|
| 2016 |
Breckwoldt MO, Bode J, Kurz FT, Hoffmann A, Ochs K, Ott M, Deumelandt K, Krüwel T, Schwarz D, Fischer M, Helluy X, Milford D, Kirschbaum K, Solecki G, Chiblak S, ... ... Platten M, et al. Correlated magnetic resonance imaging and ultramicroscopy (MR-UM) is a tool kit to assess the dynamics of glioma angiogenesis. Elife. 5. PMID 26830460 DOI: 10.7554/eLife.11712 |
0.686 |
|
| 2016 |
Sanghvi K, Green E, Bunse T, Bunse L, Sahm F, Omokoko T, Sahin U, Schmitt M, Wick W, Platten M. OS2.6 Identification of IDH1R132H-specific T cell receptors from a humanized mouse model and from glioma patients treated with an IDH1R132H-specific peptide vaccine Neuro-Oncology. 18: iv5-iv6. DOI: 10.1093/Neuonc/Now188.016 |
0.374 |
|
| 2016 |
Bunse L, Bunse T, Pusch S, Sahm F, Sanghvi K, Berghoff A, Steadman M, Niemeyer B, Wick W, Platten M. OS2.2 Paracrine impairment of antitumor T cell immunity by IDH1-mutant gliomas Neuro-Oncology. 18: iv4-iv5. DOI: 10.1093/Neuonc/Now188.012 |
0.337 |
|
| 2016 |
Thomé C, Blaes J, Sonner J, Deumelandt K, Osswald M, Breckwoldt M, Vajkoczy P, Winkler F, Platten M, Wick W. OS1.3 N-Myc downstream regulated gene 1 (NDRG1) influences the glioma tumor microenvironment Neuro-Oncology. 18: iv2-iv3. DOI: 10.1093/Neuonc/Now188.005 |
0.339 |
|
| 2015 |
Ochs K, Ott M, Rauschenbach KJ, Deumelandt K, Sahm F, Opitz CA, von Deimling A, Wick W, Platten M. Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4. Journal of Neurochemistry. PMID 26708701 DOI: 10.1111/Jnc.13503 |
0.387 |
|
| 2015 |
Wick W, Platten M, Wick A, Hertenstein A, Radbruch A, Bendszus M, Winkler F. Current status and future directions of anti-angiogenic therapy for gliomas. Neuro-Oncology. PMID 26459812 DOI: 10.1093/Neuonc/Nov180 |
0.349 |
|
| 2015 |
Redaelli C, Gaffarogullari EC, Brune M, Pilz C, Becker S, Sonner J, Jäschke A, Gröne HJ, Wick W, Platten M, Lanz TV. Toxicity of teriflunomide in aryl hydrocarbon receptor deficient mice. Biochemical Pharmacology. 98: 484-92. PMID 26341389 DOI: 10.1016/J.Bcp.2015.08.111 |
0.315 |
|
| 2015 |
Reuss DE, Kratz A, Sahm F, Capper D, Schrimpf D, Koelsche C, Hovestadt V, Bewerunge-Hudler M, Jones DT, Schittenhelm J, Mittelbronn M, Rushing E, Simon M, Westphal M, Unterberg A, ... Platten M, et al. Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathologica. PMID 26087904 DOI: 10.1007/S00401-015-1454-8 |
0.392 |
|
| 2015 |
Reuss DE, Mamatjan Y, Schrimpf D, Capper D, Hovestadt V, Kratz A, Sahm F, Koelsche C, Korshunov A, Olar A, Hartmann C, Reijneveld JC, Wesseling P, Unterberg A, Platten M, et al. IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. Acta Neuropathologica. 129: 867-73. PMID 25962792 DOI: 10.1007/S00401-015-1438-8 |
0.476 |
|
| 2015 |
Herrlinger U, Platten M. [Treatment of the glioma microenvironment]. Der Nervenarzt. 86: 684, 686-8, 690-1. PMID 25962344 DOI: 10.1007/S00115-014-4225-1 |
0.402 |
|
| 2015 |
Platten M, Wick W. Tregs in gliomas - the jury is still out. Neuro-Oncology. 17: 769-70. PMID 25754090 DOI: 10.1093/Neuonc/Nov034 |
0.416 |
|
| 2015 |
Bunse L, Schumacher T, Sahm F, Pusch S, Oezen I, Rauschenbach K, Gonzalez M, Solecki G, Osswald M, Capper D, Wiestler B, Winkler F, Herold-Mende C, von Deimling A, Wick W, ... Platten M, et al. Proximity ligation assay evaluates IDH1R132H presentation in gliomas. The Journal of Clinical Investigation. 125: 593-606. PMID 25555220 DOI: 10.1172/Jci77780 |
0.352 |
|
| 2014 |
Wick W, Fricke H, Junge K, Kobyakov G, Martens T, Heese O, Wiestler B, Schliesser MG, von Deimling A, Pichler J, Vetlova E, Harting I, Debus J, Hartmann C, Kunz C, ... Platten M, et al. A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6304-13. PMID 25338498 DOI: 10.1158/1078-0432.CCR-14-0951-T |
0.361 |
|
| 2014 |
Wiestler B, Capper D, Hovestadt V, Sill M, Jones DT, Hartmann C, Felsberg J, Platten M, Feiden W, Keyvani K, Pfister SM, Wiestler OD, Meyermann R, Reifenberger G, Pietsch T, et al. Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro-Oncology. 16: 1630-8. PMID 25028501 DOI: 10.1093/Neuonc/Nou138 |
0.387 |
|
| 2014 |
Wiestler B, Capper D, Sill M, Jones DT, Hovestadt V, Sturm D, Koelsche C, Bertoni A, Schweizer L, Korshunov A, Weiß EK, Schliesser MG, Radbruch A, Herold-Mende C, Roth P, ... ... Platten M, et al. Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta Neuropathologica. 128: 561-71. PMID 25008768 DOI: 10.1007/S00401-014-1315-X |
0.468 |
|
| 2014 |
Wick W, Platten M. CMV infection and glioma, a highly controversial concept struggling in the clinical arena. Neuro-Oncology. 16: 332-3. PMID 24523454 DOI: 10.1093/Neuonc/Nou002 |
0.378 |
|
| 2014 |
Blaes J, Weiler M, Sahm F, Hentschel B, Osswald M, Czabanka M, Thomé CM, Schliesser MG, Pusch S, Luger S, Winkler F, Radbruch A, Jugold M, Simon M, Steinbach JP, ... ... Platten M, et al. NDRG1 prognosticates the natural course of disease in WHO grade II glioma. Journal of Neuro-Oncology. 117: 25-32. PMID 24395351 DOI: 10.1007/s11060-013-1357-2 |
0.462 |
|
| 2014 |
Wick W, Wick A, Platten M. Challenging cytomegalovirus data in glioblastoma. Neuro-Oncology. 16: 165. PMID 24353326 DOI: 10.1093/Neuonc/Not212 |
0.301 |
|
| 2014 |
Wiestler B, Capper D, Hovestadt V, Sill M, Jones D, Hartmann C, Felsberg J, Platten M, Keyvani K, Pfister S, Wiestler O, Meyermann R, Reifenberger G, Pietsch T, von Deimling A, et al. Determining the glioma CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide methylation data in the biomarker cohort of the NOA-04 trial. Journal of Clinical Oncology. 32: 2017-2017. DOI: 10.1200/Jco.2014.32.15_Suppl.2017 |
0.315 |
|
| 2014 |
Wick W, Gorlia T, Van Den Bent MJ, Vecht CJ, Steuve J, Brandes AA, Platten M, Kosch MA, Hegi ME, Lhermitte B, Golfinopoulos V, Campone M, Frenel J, Taphoorn MJ, Pesce GA, et al. Radiation therapy and concurrent plus adjuvant temsirolimus (CCI-779) versus chemoirradiation with temozolomide in newly diagnosed glioblastoma without methylation of the MGMT gene promoter. Journal of Clinical Oncology. 32: 2003-2003. DOI: 10.1200/Jco.2014.32.15_Suppl.2003 |
0.326 |
|
| 2014 |
Wick W, Wiestler B, Capper D, Sill M, Hovestadt V, Schliesser MG, Weiss E, Jones DTW, Roth P, Pfister SM, Korshunov A, Platten M, Reifenberger G, von Deimling A, Weller M. PROGNOSTIC AND PREDICTIVE BIOMARKER-BASED SUBGROUPS IN THE NOA-04 TRIAL Neuro-Oncology. 16: iii4-iii4. DOI: 10.1093/Neuonc/Nou206.14 |
0.382 |
|
| 2013 |
Koelsche C, Sahm F, Capper D, Reuss D, Sturm D, Jones DT, Kool M, Northcott PA, Wiestler B, Böhmer K, Meyer J, Mawrin C, Hartmann C, Mittelbronn M, Platten M, et al. Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathologica. 126: 907-15. PMID 24154961 DOI: 10.1007/S00401-013-1195-5 |
0.449 |
|
| 2013 |
Lanz TV, Becker S, Osswald M, Bittner S, Schuhmann MK, Opitz CA, Gaikwad S, Wiestler B, Litzenburger UM, Sahm F, Ott M, Iwantscheff S, Grabitz C, Mittelbronn M, von Deimling A, ... ... Platten M, et al. Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. 110: 14735-40. PMID 23959874 DOI: 10.1073/Pnas.1302569110 |
0.327 |
|
| 2013 |
Wick W, Steinbach JP, Platten M, Hartmann C, Wenz F, von Deimling A, Shei P, Moreau-Donnet V, Stoffregen C, Combs SE. Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation. Neuro-Oncology. 15: 1405-12. PMID 23911595 DOI: 10.1093/Neuonc/Not100 |
0.477 |
|
| 2013 |
Platten M, Wick W, Opitz C. [Immune modulation by tryptophan metabolism: relevance for autoimmune and tumor diseases]. Deutsche Medizinische Wochenschrift (1946). 138: 1478-82. PMID 23821452 DOI: 10.1055/S-0033-1343222 |
0.329 |
|
| 2013 |
Wiestler B, Capper D, Holland-Letz T, Deimling Av, Pfister SM, Platten M, Weller M, Wick W. Abstract LB-80: ATRX loss refines the classification of anaplastic glioma and is a favorable prognostic marker. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-80 |
0.389 |
|
| 2012 |
Platten M, Weller M, Wick W. Shaping the glioma immune microenvironment through tryptophan metabolism. Cns Oncology. 1: 99-106. PMID 25054303 DOI: 10.2217/Cns.12.6 |
0.396 |
|
| 2012 |
Platten M, Wick W, Van den Eynde BJ. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Research. 72: 5435-40. PMID 23090118 DOI: 10.1158/0008-5472.Can-12-0569 |
0.388 |
|
| 2012 |
Ott M, Litzenburger UM, Sahm F, Rauschenbach KJ, Tudoran R, Hartmann C, Marquez VE, von Deimling A, Wick W, Platten M. Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase. Plos One. 7: e47663. PMID 23077658 DOI: 10.1371/journal.pone.0047663 |
0.451 |
|
| 2012 |
Platten M, Wick W. [Treatment of brain tumor patients: hyperthermia, hyperbaric oxygenation, electric fields or nanoparticles]. Der Nervenarzt. 83: 982-7. PMID 22801663 DOI: 10.1007/S00115-012-3569-7 |
0.35 |
|
| 2011 |
Opitz CA, Litzenburger UM, Opitz U, Sahm F, Ochs K, Lutz C, Wick W, Platten M. The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells. Plos One. 6: e19823. PMID 21625531 DOI: 10.1371/Journal.Pone.0019823 |
0.352 |
|
| 2011 |
Seidel C, Dörner N, Osswald M, Wick A, Platten M, Bendszus M, Wick W. Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma. Bmc Cancer. 11: 127. PMID 21481277 DOI: 10.1186/1471-2407-11-127 |
0.376 |
|
| 2010 |
Platten M, Dörner N, Hofer S, Schäfer N, Schemmer D, Weller M, Bendszus M, Wick W, Wick A. Evaluation of distant spread in bevacizumab-treated versus control-treated patients with malignant gliomas: A matched-pair study. Journal of Clinical Oncology. 28: 2064-2064. DOI: 10.1200/Jco.2010.28.15_Suppl.2064 |
0.397 |
|
| 2009 |
Platten M, Youssef S, Hur EM, Ho PP, Han MH, Lanz TV, Phillips LK, Goldstein MJ, Bhat R, Raine CS, Sobel RA, Steinman L. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proceedings of the National Academy of Sciences of the United States of America. 106: 14948-53. PMID 19706421 DOI: 10.1073/Pnas.0903958106 |
0.315 |
|
| 2009 |
Combs SE, Hartmann C, Welzel J, von Deimling A, Debus J, Platten M, Wick W, Gaiser T. Influence of expression of EGFR and PTEN on outcome in patients with primary glioblastoma treated with standard radiochemotherapy and cetuximab: Interim analysis from the GERT-Protocol Journal of Clinical Oncology. 27: 2050-2050. DOI: 10.1200/Jco.2009.27.15_Suppl.2050 |
0.327 |
|
| 2009 |
Platten M. Tumorprogress versus therapieinduzierte Veränderungen (Pseudoprogression) bei malignen Astrozytomen Onkopipeline. 2: 16-18. DOI: 10.1007/S15035-009-0139-Y |
0.367 |
|
| 2008 |
Combs SE, Schulz-Ertner D, Hartmann C, Welzel T, Timke C, Herfarth K, von Deimling A, Edler L, Platten M, Wick W, Debus J. Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)—Eudract number 2005–003911–63; NCT00311857 Journal of Clinical Oncology. 26: 2077-2077. DOI: 10.1200/Jco.2008.26.15_Suppl.2077 |
0.311 |
|
| 2007 |
Wick A, Felsberg J, Steinbach JP, Herrlinger U, Platten M, Blaschke B, Meyermann R, Reifenberger G, Weller M, Wick W. Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3357-61. PMID 17664483 DOI: 10.1200/Jco.2007.10.7722 |
0.338 |
|
| 2007 |
Wick W, Wick A, Schuth J, Platten M, Reifenberger G, Weller M. One week on/one week off regimen of temozolomide: Phase II trial in recurrent glioma Journal of Clinical Oncology. 25: 2032-2032. DOI: 10.1200/Jco.2007.25.18_Suppl.2032 |
0.334 |
|
| 2005 |
Platten M, Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, Gupta R, Lee LY, Kidd BA, Robinson WH, Sobel RA, Selley ML, Steinman L. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science (New York, N.Y.). 310: 850-5. PMID 16272121 DOI: 10.1126/Science.1117634 |
0.301 |
|
| 2000 |
Roth W, Wild-Bode C, Platten M, Grimmel C, Melkonyan HS, Dichgans J, Weller M. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene. 19: 4210-20. PMID 10980594 DOI: 10.1038/Sj.Onc.1203783 |
0.355 |
|
| 1997 |
Platten M, Meyer-Puttlitz B, Blümcke I, Waha A, Wolf HK, Nöthen MM, Louis DN, Sampson JR, von Deimling A. A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas. Journal of Neuropathology and Experimental Neurology. 56: 806-10. PMID 9210877 DOI: 10.1097/00005072-199756070-00007 |
0.519 |
|
| 1996 |
Platten M, Giordano MJ, Dirven CM, Gutmann DH, Louis DN. Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas. The American Journal of Pathology. 149: 621-7. PMID 8702000 |
0.427 |
|
| Show low-probability matches. |